Full cycle pharmacovigilance professional with extensive experience in safety monitoring and data management. Proven expertise in adverse event reporting, coupled with exceptional customer service skills in study start-up, maintenance, and close-out.
Certifications
Greiner, M. G., Shulman, M., Opara, O., Potter, K., Voronca, D. C., Tafessu, H. M., Hefner, K., Hamilton, A., Scheele, C., Ho, R., Dresser, L., Jelstrom, E., Fishman, M., Ghitza, U. E., Rotrosen, J., Nunes, E. V., Bisaga, A., Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study., Contemporary clinical trials, 128, 107148, 2023, https://doi.org/10.1016/j.cct.2023.107148
Runner Up: “Government Study/Team of the Year” (Team Member), 2024 Science Symposium, The Emmes Company, LLC
CITI (Collaborative IRB Training Initiative) Certified, 2021-Present
MedDRA Coding Certificate, 2022-Present
WHODrug Coding Certificate, 2022-Present